老虎证券

美股详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务

Crescent Biopharma Inc

19.45
-0.5000-2.51%
盘后：19.20-0.2500-1.29%19:06 EDT
成交量：7.39万
成交额：143.96万
市值：5.36亿
市盈率：-1.52
高：19.89
开：19.77
低：19.05
收：19.95
52周最高：28.77
52周最低：8.72
股本：2,755.68万
流通股本：1,087.10万
量比：0.28
换手率：0.68%
股息：- -
股息率：- -
每股收益(TTM):-12.8150
每股收益(LYR):-12.8150
净资产收益率：-160.75%
总资产收益率：-69.15%
市净率：7.39
市盈率(LYR):-1.52

数据加载中...

总览公司新闻资讯公告
2020/06/16

重要事件披露

8-K - Current report
2020/05/11

重要事件披露

8-K - Current report
2020/05/11

季度报告

Quarterly report [Sections 13 or 15(d)]
2020/03/20

重要事件披露

Current report, item 5.02
2020/02/21

重要事件披露

Current report, items 2.02 and 9.01
2020/02/20

年度报告

Annual report [Section 13 and 15(d), not S-K Item 405]
2020/02/14

重要事件披露

Current report, items 1.01, 2.02, 8.01, and 9.01
2020/02/12

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/12

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/11

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/07

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/07

重要事件披露

Current report, item 8.01
2020/02/07

重要事件披露

Current report, items 7.01 and 9.01
2020/01/29

重要事件披露

Current report, item 5.02
2020/01/17

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/17

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2020/01/17

重要事件披露

Current report, items 1.01, 5.02, 8.01, and 9.01
2020/01/08

重要事件披露

Current report, items 7.01 and 9.01
2019/12/31

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/12/20

重要事件披露

Current report, items 1.01 and 9.01
更多